267 related articles for article (PubMed ID: 8895234)
1. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
3. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
[TBL] [Abstract][Full Text] [Related]
4. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
6. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
7. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
8. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence.
McLemore GL; Kest B; Inturrisi CE
Brain Res; 1997 Dec; 778(1):120-6. PubMed ID: 9462883
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
11. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
[TBL] [Abstract][Full Text] [Related]
13. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
Shoemaker WJ; Kosten TA; Muly SM
Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
[TBL] [Abstract][Full Text] [Related]
14. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
[TBL] [Abstract][Full Text] [Related]
15. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Farzin D
Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
[TBL] [Abstract][Full Text] [Related]
16. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
18. Ethanol enhances naloxone sensitization and disrupts morphine discrimination--comparison to dizocilpine and pentobarbital: explanation of enhancing acute and attenuating chronic effects.
Kosten TA; Bombace JC
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1283-306. PubMed ID: 11474846
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats.
Mao J; Price DD; Caruso FS; Mayer DJ
Pain; 1996 Oct; 67(2-3):361-8. PubMed ID: 8951930
[TBL] [Abstract][Full Text] [Related]
20. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
Cook CD; Barrett AC; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):93-104. PubMed ID: 11041321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
